Aethlon Medical Stock (NASDAQ:AEMD)


OwnershipFinancialsChartTranscripts

Previous Close

$1.33

52W Range

$1.10 - $8.48

50D Avg

$1.97

200D Avg

$3.35

Market Cap

$3.31M

Avg Vol (3M)

$248.75K

Beta

1.69

Div Yield

-

AEMD Company Profile


Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

14

IPO Date

Mar 04, 1999

Website

AEMD Performance


AEMD Financial Summary


Mar 25Mar 24Mar 23
Revenue--$574.25K
Operating Income-$-12.64M$-11.90M
Net Income$-13.39B$-12.21M$-12.03M
EBITDA-$-11.85M$-11.66M
Basic EPS$-8.58$-4.86$-5.86
Diluted EPS$-8.58$-4.86$-5.90

Fiscal year ends in Mar 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Jun 26, 25 | 4:30 PM
Q3 25Feb 12, 25 | 4:30 PM
Q2 25Nov 13, 24 | 4:30 PM

Peer Comparison


TickerCompany
GOVXGeoVax Labs, Inc.
APDNApplied DNA Sciences, Inc.
BBLGBone Biologics Corporation
CTSOCytosorbents Corporation
TIVCTivic Health Systems, Inc.